The U.S. must do some heavy lifting to prepare for heritable genome editing
By Josephine Johston,
STAT
| 09. 04. 2020
Countries contemplating giving the green light to heritable genome editing received specific guidance from an international commission this week on how to prepare for a future in which the technology is safe and effective enough to use in human reproduction.
The commission was created in response to the news almost two years ago that a scientist in China had edited the genomes of two babies when they were single-cell embryos. (It subsequently emerged that a third baby with an edited genome had been born.)
While the scientist involved, He Jiankui, was widely condemned for conducting a premature and unethical experiment, and later fined and sentenced to jail, his first-in-humans experiment pushed the international community beyond a “germline editing — good or bad?” discussion to actively considering what it would take to justify its use.
Germline gene editing raises particular ethical and safety issues. Gene editing in a young child or adult creates changes that may affect the individual, but are not passed on to his or her children. Germline editing, also known as heritable genome editing, creates changes that...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...